FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1497013683> ?p ?o ?g. }

• W1497013683 endingPage "36" @default.
• W1497013683 startingPage "30" @default.
• W1497013683 abstract "Recent studies have indicated the prognostic value of tumour subtype and pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). However these results were reported after a short follow-up and using a standard Cox model which could be unsatisfactory for time-dependent factors. In the present study, we identified the prognostic factors for long-term outcome after NAC, considering that they could have an inconstant impact over time.Prognostic factors from 956 consecutive breast cancer patients treated with NAC were identified and associated with long-term outcomes. We estimated survival by a time function multivariate Cox model regression and stratified by follow-up length.The prognostic value of tumour histological grade and hormone receptors status varied as distant recurrence-free interval (DRFI) increased. The multivariate analysis identified the following significant prognostic factors: tumour size, N stage, clinical and pathological response to NAC, hormone receptors (HR) status and histological tumour grade. The 'prognostic benefit' of low-grade and positive-HR status decreased over the years. Thus, in the early years after cancer diagnosis, the hazard ratio of distant recurrences in patients with positive-HR status increased from 0.26 (95% CI 0.1-0.4) at 6 months to 2.2 (95% CI 1.3-3.7) at 120 months. The histological tumour grade followed a similar trend. The hazard ratio of grade III patients compared with grade I was 1.83 (95% CI 1.1-2.8) at 36 months and diminished over time to 0.70 (95% CI 0.4-1.3) at 120 months. This indicates that the risk of recurrence for positive-HR patients was 74% lower at 6 months compared with the negative-hormone receptor group, but 30% higher at 5 years and more than double at 10 years. High-grade tumours presented a risk of 83% in the earlier years decreasing to 30% at 10 years versus the low-grade group.From the present study, we conclude the importance of identifying time-dependent prognostic factors. Distant recurrence-free interval within women who receive NAC are influenced by achieving pCR and breast cancer subtype. Tumours with more aggressive biology have poorer survival during the first 5 years, but if they exceed this point their prognostic impact is no longer significant. Conversely, positive-HR patients remain at risk for distant recurrence for many years." @default.
• W1497013683 created "2016-06-24" @default.
• W1497013683 creator A5001576142 @default.
• W1497013683 creator A5003301011 @default.
• W1497013683 creator A5010020212 @default.
• W1497013683 creator A5010351321 @default.
• W1497013683 creator A5032783305 @default.
• W1497013683 creator A5034058277 @default.
• W1497013683 creator A5042051747 @default.
• W1497013683 creator A5052025477 @default.
• W1497013683 creator A5071567585 @default.
• W1497013683 creator A5084210907 @default.
• W1497013683 creator A5091592799 @default.
• W1497013683 date "2015-06-01" @default.
• W1497013683 modified "2023-10-08" @default.
• W1497013683 title "Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy" @default.
• W1497013683 cites W1881540319 @default.
• W1497013683 cites W1961026612 @default.
• W1497013683 cites W1965427258 @default.
• W1497013683 cites W1989536725 @default.
• W1497013683 cites W2010871781 @default.
• W1497013683 cites W2038981426 @default.
• W1497013683 cites W2044702943 @default.
• W1497013683 cites W2052136718 @default.
• W1497013683 cites W2053074390 @default.
• W1497013683 cites W2071205059 @default.
• W1497013683 cites W2075894019 @default.
• W1497013683 cites W2077428858 @default.
• W1497013683 cites W2090539023 @default.
• W1497013683 cites W2096145980 @default.
• W1497013683 cites W2118605519 @default.
• W1497013683 cites W2118804515 @default.
• W1497013683 cites W2119549339 @default.
• W1497013683 cites W2121411897 @default.
• W1497013683 cites W2136839015 @default.
• W1497013683 cites W2144400406 @default.
• W1497013683 cites W2147415463 @default.
• W1497013683 cites W2147908679 @default.
• W1497013683 cites W2150448289 @default.
• W1497013683 cites W2154142993 @default.
• W1497013683 cites W2161977537 @default.
• W1497013683 cites W2164774797 @default.
• W1497013683 cites W2172198909 @default.
• W1497013683 cites W2398842279 @default.
• W1497013683 cites W2409028183 @default.
• W1497013683 cites W35647293 @default.
• W1497013683 doi "https://doi.org/10.1038/bjc.2015.174" @default.
• W1497013683 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4647542" @default.
• W1497013683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26079300" @default.
• W1497013683 hasPublicationYear "2015" @default.
• W1497013683 type Work @default.
• W1497013683 sameAs 1497013683 @default.
• W1497013683 citedByCount "25" @default.
• W1497013683 countsByYear W14970136832016 @default.
• W1497013683 countsByYear W14970136832017 @default.
• W1497013683 countsByYear W14970136832018 @default.
• W1497013683 countsByYear W14970136832019 @default.
• W1497013683 countsByYear W14970136832020 @default.
• W1497013683 countsByYear W14970136832021 @default.
• W1497013683 countsByYear W14970136832022 @default.
• W1497013683 countsByYear W14970136832023 @default.
• W1497013683 crossrefType "journal-article" @default.
• W1497013683 hasAuthorship W1497013683A5001576142 @default.
• W1497013683 hasAuthorship W1497013683A5003301011 @default.
• W1497013683 hasAuthorship W1497013683A5010020212 @default.
• W1497013683 hasAuthorship W1497013683A5010351321 @default.
• W1497013683 hasAuthorship W1497013683A5032783305 @default.
• W1497013683 hasAuthorship W1497013683A5034058277 @default.
• W1497013683 hasAuthorship W1497013683A5042051747 @default.
• W1497013683 hasAuthorship W1497013683A5052025477 @default.
• W1497013683 hasAuthorship W1497013683A5071567585 @default.
• W1497013683 hasAuthorship W1497013683A5084210907 @default.
• W1497013683 hasAuthorship W1497013683A5091592799 @default.
• W1497013683 hasBestOaLocation W14970136831 @default.
• W1497013683 hasConcept C10515644 @default.
• W1497013683 hasConcept C121608353 @default.
• W1497013683 hasConcept C126322002 @default.
• W1497013683 hasConcept C143998085 @default.
• W1497013683 hasConcept C146357865 @default.
• W1497013683 hasConcept C151730666 @default.
• W1497013683 hasConcept C207103383 @default.
• W1497013683 hasConcept C207886595 @default.
• W1497013683 hasConcept C23589133 @default.
• W1497013683 hasConcept C2776694085 @default.
• W1497013683 hasConcept C38180746 @default.
• W1497013683 hasConcept C44249647 @default.
• W1497013683 hasConcept C50382708 @default.
• W1497013683 hasConcept C530470458 @default.
• W1497013683 hasConcept C71924100 @default.
• W1497013683 hasConcept C86803240 @default.
• W1497013683 hasConcept C90924648 @default.
• W1497013683 hasConceptScore W1497013683C10515644 @default.
• W1497013683 hasConceptScore W1497013683C121608353 @default.
• W1497013683 hasConceptScore W1497013683C126322002 @default.
• W1497013683 hasConceptScore W1497013683C143998085 @default.
• W1497013683 hasConceptScore W1497013683C146357865 @default.
• W1497013683 hasConceptScore W1497013683C151730666 @default.
• W1497013683 hasConceptScore W1497013683C207103383 @default.

• next